Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coreg CR Approved; GSK Plans First Quarter 2007 Launch

This article was originally published in The Pink Sheet Daily

Executive Summary

Micropump technology licensed from French drug delivery firm Flamel modulates release of GSK’s carvedilol over 24 hours.

You may also be interested in...



Generic Coreg To Launch Immediately Following FDA Approval

Several generic drug makers received ANDA approval for generic versions of GlaxoSmithKline’s blockbuster heart failure medication.

Generic Coreg To Launch Immediately Following FDA Approval

Several generic drug makers received ANDA approval for generic versions of GlaxoSmithKline’s blockbuster heart failure medication.

Coreg CR Opens New Opportunity In Hypertension, GSK’s Stout Says

The once-daily formulation of carvedilol will make it a more attractive option for hypertension than the previous Coreg.

Related Content

Topics

UsernamePublicRestriction

Register

MT003605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel